New York, NY, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Allergy Immunotherapy Market by Treatment Type (SCIT and SLIT), by Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Stores, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global allergy immunotherapy market was approximately USD 1.87 billion in 2018 and is expected to generate around USD 3.76 billion by 2025, at a CAGR of around 10.5% between 2019 and 2025.
Allergy immunotherapy is a type of immunotherapy where the person suffering from certain any kind of allergy is exposed to a particular type of allergen till the time his/her immune system modifies. The growing prevalence of allergies like allergy rhinitis, asthma, and food allergy, the introduction of various immunotherapy technologies, increasing R&D activities for developing immunotherapies against allergies, and rising awareness about the benefits of allergy immunotherapy are some the major factors fueling the global for allergy immunotherapy market.
Browse through 54 Tables & 27 Figures spread over 110 Pages and in-depth TOC on “Global Allergy Immunotherapy Market Size, Share 2018: By Type, Segments, Industry Trends, Analysis and Forecast to 2025”.
Request Sample Report of Global Allergy Immunotherapy Market @ https://www.zionmarketresearch.com/sample/allergy-immunotherapy-market
The allergy immunotherapy market is fragmented on the basis of allergy type, treatment type, and distribution channel. Based on treatment type, the market includes subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). The SCIT segment is anticipated to dominate the market in the years ahead, owing to its effectiveness to treat various allergies like asthma. Additionally, SCIT is a treatment option that alters one’s immune system to prevent the development of other allergies.
By allergy type, the market for allergy immunotherapy is divided into asthma, venom allergy, food allergy, allergic rhinitis, and others. Allergic rhinitis is expected to dominate the market for allergy immunotherapy. According to the CDC, about 8% of the total population in the U.S. is suffering from allergy rhinitis. Thus, the growing prevalence of this allergy among adults as well as children is anticipated to fuel this segment’s growth in the upcoming years. Additionally, the asthma segment is expected to show a higher growth rate in the future, owing to the growing asthma prevalence worldwide.
Request for PDF Brochure of This Report: https://www.zionmarketresearch.com/requestbrochure/allergy-immunotherapy-market
The distribution channel segment of the allergy immunotherapy market comprises retail pharmacy and drug stores, online pharmacy, and hospital pharmacy. The hospital pharmacy segment is projected to dominate the market for allergy immunotherapy globally in the future, owing to the growing patient pool in hospitals worldwide for allergy treatment.
Europe is projected to dominate the allergy immunotherapy market, owing to the early introduction of immunotherapy treatments, presence of major players in this region, presence of highly developed treatment technologies and developed healthcare infrastructure, and rising number of supportive reimbursement policies by the government. According to the European Academy of Allergy and Clinical Immunology, in 2014, about 150 million Europeans suffered from various chronic allergies and it was projected that by 2025, about 50% of Europeans will suffer from various allergies. This increasing allergy prevalence is due to the presence of a large geriatric population, which is expected to further fuel this regional market.
Browse the full “Allergy Immunotherapy Market by Treatment Type (SCIT and SLIT), by Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Stores, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/allergy-immunotherapy-market
North America acquired the second largest share of the allergy immunotherapy market in 2018 globally. According to the CDC, about 8% of the total population in the U.S. suffers from allergy rhinitis. Additionally, the CDC also stated that about 50 million Americans suffer from some kind of allergies. Growing prevalence of allergies in North America, availability of advanced healthcare infrastructure, the introduction of various treatment technologies, and growing research and development activities are fueling this regional market for allergy immunotherapy.
The Asia Pacific allergy immunotherapy market is anticipated to show the highest growth rate in the upcoming years, owing to the rising investments and funding by the government for R&D, increasing number of people suffering from allergies, growing awareness about the benefits of allergy immunotherapy to treat various allergies, and the introduction of immunotherapy in the developing countries of China and India. According to the National Health Portal of India, about 20 to 30% of Indians suffer from some kind of allergy. Out of this, about 15% of them suffer from asthma. The high pollution rate in major cities of India is increasing the number of people suffering from allergies, which is mainly fueling the allergy immunotherapy market in the Asia Pacific.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/allergy-immunotherapy-market
The Middle Eastern and African and Latin American regions are forecasted to show sturdy market growth rates, owing to rapid developments witnessed in healthcare infrastructure, increasing the prevalence of allergies and chronic diseases, and growing investments by the government for research and development.
Some major players involved in the global allergy immunotherapy market are Abello, Aimmune Therapeutics, Stallergenes Greer, Allergy Therapeutics, Biomay, Merck, DBV Technologies, Circassia, HAL Allergy, and Anergis.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/4511
This report segments the global allergy immunotherapy market as follows:
Global Allergy Immunotherapy Market: Treatment Type Analysis
- SCIT
- SLIT
Global Allergy Immunotherapy Market: Allergy Type Analysis
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
Global Allergy Immunotherapy Market: Distribution Channel Analysis
- Hospital Pharmacy
- Retail Pharmacy and Drug Stores
- Online Pharmacy
Global Allergy Immunotherapy Market: Regional Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Generic Oncology Drugs Market: https://www.zionmarketresearch.com/report/generic-oncology-drugs-market
- Opioid Tolerance Treatment Market: https://www.zionmarketresearch.com/report/opioid-tolerance-treatment-market
- Plasma Fractionation Market: https://www.zionmarketresearch.com/report/plasma-fractionation-market
- Smart Pills Market: https://www.zionmarketresearch.com/report/smart-pills-market
- Pharmacovigilance Market: https://www.zionmarketresearch.com/report/pharmacovigilance-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Visit Our Blog: https://blackmartappz.com | Web Series Reviews | http://newszmr.com | http://zmrnewsnetwork.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://newszmr.com